Search

Search Results

• Pola-R-CHP Regimen as First-Line Therapy for Diffuse Large B-Cell Lymphoma: A Retrospective Study of Real-World Clinical Practice

  Anastasiya Aleksandrovna Semenova, G.S. Tumyan, Yu.V. Ermakova, A.S. Chuprakova, A.P. Chernova, M.V. Frolova, N.B. Mikhailova, L.V. Fedorova, O.D. Serdyuk, S.V. Samarina, N.V. Nikolaeva, I.B. Lysenko, L.F. Mukharlyamova, G.N. Khusainova, N.V. Medvedeva, Ya.K. Mangasarova, A.Yu. Kuvshinov, D.V. Zaytsev, E.V. Karyagina, V.V. Denisova, T.I. Pospelova, I.N. Nechunaeva, K.S. Dedyukhina, N.G. Gabeeva, E.E. Zvonkov, A.D. Vorobev, O.S. Samoilova, I.V. Poddubnaya, Yu.V. Batukhtina, R.A. Zukov, E.N. Babich, T.N. Aleksandrova, I.S. Verkhoglyad, N.N. Glonina, I.Yu. Kudinova, E.A. Ukrainchenko, T.M. Sycheva, N.G. Ipatova, A.V. Proidakov, V.S. Morozov, G.Yu. Vyskub, V.V. Kobzev, E.V. Anikina, T.I. Ksenzova, Ya.V. Belenkaya, N.O. Zemlyakov

  241-252

  01.07.2026

• Quality of Life and Symptom Profile in Polycythemia Vera Patients on Ruxolitinib Therapy in a Real-World Setting: Results of a Multi-Center Prospective Observational Study

  T.I. Ionova, Tatyana Pavlovna Nikitina, A.V. Proidakov, E.V. Lyurova, E.M. Volodicheva, L.A. Mkhitaryan, Yu.P. Martinova, T.V. Chitanava, N.B. Esefeva, M.O. Ivanova, T.I. Pospelova, A.S. Lyamkina, E.A. Knyazeva, E.G. Lomaia, N.S. Lazorko, K.P. Novoselov, D.A. Lipatova, N.M. Porfirieva, A.D. Kulagin

  14-26

  01.01.2026

• Determination of the Minimal Residual Disease Threshold in Acute Myeloid Leukemia Treated with ‘ОМЛ-17’ and ‘mОМЛ-17’ Regimens

  Irina Vladimirovna Galtseva, E.N. Parovichnikova, K.A. Nikiforova, Yu.O. Davydova, N.M. Kapranov, I.A. Lukianova, A.A. Ievleva, Yu.A. Chabaeva, Z.T. Fidarova, L. A. Kuzmina, V.V. Troitskaya, T.V. Gaponova, S.M. Kulikov

  340-346

  01.10.2025

• Effectiveness of the Initial Escalation of Immunochemotherapy in Patients with High Risk MALT-Lymphoma: Pilot Study Results

  Anna Konstantinovna Smol’yaninova, N.G. Gabeeva, S.A. Tatarnikova, A.V. Belyaeva, A.M. Kovrigina, E.G. Gemdzhyan, E.E. Zvonkov

  338-348

  01.07.2025

• Options for Program Chemotherapy and Their Outcomes in Patients with Newly Diagnosed Mantle Cell Lymphoma Based on the Data from a Single Center

  Ulyana Gordeevna Koshkina, G.S. Tumyan, A.A. Semenova, M.Yu. Kichigina, I.Z. Zavodnova, D.N. Tupitsyna, E.V. Paramonova, A.S. Antipova, V.O. Shpirko, Yu.I. Klyuchagina, S.F. Ramazanova, A.V. Arakelyan, G.D. Petrova, O.Yu. Baranova, N.A. Kupryshina, E.A. Osmanov

  121-133

  01.04.2025

• Diffuse Large B-Cell Lymphoma with High Risk of Central Nervous System Damage: A Literature Review, Prevention, Treatment, and Prognosis

  Selmi Faikovna Ramazanova, A.V. Arakelyan, A.A. Semenova, O.Yu. Baranova, D.N. Tupitsyna, M.Yu. Kichigina, I.Z. Zavodnova, E.V. Paramonova, A.S. Antipova, V.O. Shpirko, Yu.I. Klyuchagina, U.G. Koshkina, G.S. Tumyan

  51-64

  01.01.2025

• Primary Prevention of Neutropenia by Empegfilgrastim in Patients with Advanced Stages of Classical Hodgkin Lymphoma Treated with Intensive First-Line Chemotherapy with a Modified 6-Cycle Program EACODD-14 Under the Protocol “LKh-Rossiya-1”

  Anna Anatolevna Spornik, N.S. Vasilev, A.A. Samoilova, A.A. Mamedova, V.S. Bogatyrev, E.G. Smirnova, A.A. Bannikova, A.A. Rukavitsyn, N.S. Shorokhov, N.E. Mochkin, V.O. Sarzhevskii, E.A. Demina, V.Ya. Melnichenko

  370-379

  28.09.2023

• Ibrutinib Efficacy in First-Line Therapy of High-Risk Patients Vs. Second- and Third-Line Therapies of Resistant Chronic Lymphocytic Leukemia

  Nadezhda Viktorovna Kurkina, E.A. Repina, P.V. Volkova, A.A. Repin

  209-212

  03.03.2023

• Approaches to the Treatment of Patients with Myelofibrosis and Polycythemia Vera with Constitutional Symptoms in Real-World Clinical Practice in the Russian Federation: Intermediate Results of a Multi-Center Observational Prospective Clinical Study

  Anait Levonovna Melikyan, I.N. Subortseva, S.M. Kulikov, Yu.A. Chabaeva, E.A. Gilyazitdinova, K.P. Novoselov, E.A. Knyazeva, A.S. Egorova, I.S. Stepochkin, E.V. Koroleva, T.M. Sycheva, V.P. Belgesova, A.Yu. Putintseva, O.M. Senderova, I.V. Vasil’eva, E.Yu. Komartseva, A.A. Kaplina, V.I. Bakhtina, M.A. Mikhalev, Yu.B. Chernykh, E.N. Parovichnikova

  146-153

  03.03.2023

• Chronic Hepatitis С and Oncohematological Diseases

  Tamara Vasilevna Antonova, M.S. Nozhkin, D.A. Lioznov

  46-53

  01.01.2023

• Protocol ALL-IC BFM 2002: Outcomes of Pediatric Acute Lymphoblastic Leukemia Treatment under Multi-Center Clinical Trial

  Timur Teimurazovich Valiev, M.A. Shervashidze, I.V. Osipova, T.I. Burlutskaya, N.A. Popova, N.S. Osmulskaya, G.A. Aleskerova, S.L. Sabantsev, Z.S. Gordeeva, V.Yu. Smirnov, O.A. Poberezhnaya, S.N. Yuldasheva, I.A. Babich, N.A. Batmanova, S.R. Varfolomeeva

  119-129

  01.04.2022

• Ibrutinib as First-Line Therapy in High-Risk Chronic Lymphocytic Leukemia: Case Reports

  Nadezhda Viktorovna Kurkina, E.A. Repina

  488-495

  01.10.2021

• Value of PD-L1 Protein Expression in the Combined Prognostic Model of Diffuse Large B-Cell Lymphoma

  Svetlana Valerevna Samarina, N.Yu. Semenova, N.V. Minaeva, D.A. Dyakonov, V.A. Rosin, E.V. Vaneeva, S.V. Gritsaev

  308-314

  01.07.2021

• Comparative Analysis of Myelofibrosis Treatment Outcomes with the Use of Ruxolitinib Versus Ruxolitinib with Subsequent Allogeneic Hematopoietic Stem Cell Transplantation

  Mariya Vladimirovna Barabanshchikova, E.V. Morozova, Yu.Yu. Vlasova, T.L. Gindina, A.V. Evdokimov, I.M. Barkhatov, V.V. Baikov, I.O. Ivanova, T.A. Rudakova, E.A. Bakin, I.S. Moiseev, A.D. Kulagin

  22-30

  01.01.2021

• Comorbidity and Personalized Treatment of Multiple Myeloma in Real Clinical Practice

  Nataliya Valer’evna Skvortsova, I.B. Kovynev, K.V. Khalzov, T.I. Pospelova, I.N. Nechunaeva

  322-334

  01.07.2020

• Prognostic Value of Next-Generation Sequencing Data in Patients with Myelodysplastic Syndrome

  Nikolai Yur’evich Tsvetkov, E.V. Morozova, I.M. Barkhatov, I.S. Moiseev, M.V. Barabanshchikova, A.V. Tishkov, D.S. Bug, N.V. Petukhova, E.A. Izmailova, S.N. Bondarenko, B.V. Afanasyev

  170-175

  01.04.2020

• Immunohistochemical Subtype and Parameters of International Prognostic Index in the New Prognostic Model of Diffuse Large B-Cell Lymphoma

  S.V. Samarina, A.S. Luchinin, N.V. Minaeva, I.V. Paramonov, D.A. D’yakonov, E.V. Vaneeva, V.A. Rosin, S.V. Gritsaev

  385-390

  01.10.2019

• Infectious Complications after Haploidentical Hematopoietic Stem Cells Transplantation in Patients with High-Risk Tumors of Hematopoietic and Lymphoid Tissues: A Single-Center Experience

  Yurii Sergeevich Osipov, S.S. Bessmeltsev, G.N. Salogub, V.V. Ivanov, E.S. Mikhailov, N.A. Zhukova, A.V. Chechetkin

  406-415

  01.10.2019

• Prediction of FLAG ± Ida Regimen Efficacy in Patients with Relapsed/Refractory Acute Myeloid Leukemia

  Irina Garmaevna Budaeva, E.G. Ovsyannikova, E.N. Goryunova, O.V. Kulemina, D.V. Zaitsev, D.V. Motorin, R.Sh. Badaev, D.B. Zammoeva, V.V. Ivanov, K.V. Bogdanov, O.S. Pisotskaya, Yu.V. Mirolyubova, T.S. Nikulina, Yu.A. Alekseeva, A.Yu. Zaritskey, L.L. Girshova

  289-296

  01.07.2019

• Blinatumomab in the Treatment of Acute Lymphoblastic Leukemia: Russian Multicenter Clinical Trial

  Sergei Nikolaevich Bondarenko, E.N. Parovichnikova, A.A. Maschan, O.Yu. Baranova, T.V. Shelekhova, V.A. Doronin, V.Ya. Mel’nichenko, K.D. Kaplanov, O.S. Uspenskaya, A.N. Sokolov, N.V. Myakova, I.S. Moiseev, I.V. Markova, E.I. Darskaya, A.G. Smirnova, T.A. Bykova, B.I. Ayubova, I.A. Samorodova, E.V. Babenko, I.M. Barkhatov, T.L. Gindina, A.D. Kulagin, B.V. Afanas’ev

  145-153

  01.04.2019

• Analysis Results of the Regional Registry of Patients with Diffuse Large B-cell Lymphoma: Risk Factors and Chemo-Immunotherapy Issues

  Kamil’ Daniyalovich Kaplanov, N.P. Volkov, T.Yu. Klitochenko, I.V. Matveeva, A.L. Shipaeva, M.N. Shirokova, N.V. Davydova, E.G. Gemdzhian, D.S. Abramov, D.M. Konovalov, G.L. Snigur, N.A. Red’kina

  154-164

  01.04.2019

• Diagnosis of Acute Lymphoblastic Leukemia Originating From T-Lineage Precursors and Approaches to Minimal Residual Disease Monitoring

  Ol’ga Alekseevna Chernysheva, L.Yu. Grivtsova, I.N. Serebryakova, N.A. Kupryshina, E.N. Sholokhova, M.A. Shervashidze, A.D. Palladina, B.V. Kurdyukov, A.V. Popa, N.N. Tupitsyn

  79-85

  01.01.2019

• First-Line Treatment of Mantle-Cell Lymphoma: Analysis of Effectiveness and Cost-Effectiveness

  Kamil’ Daniyalovich Kaplanov, N.P. Volkov, T.Yu. Klitochenko, A.L. Shipaeva, I.V. Matveeva, M.N. Shirokova, A.C. Proskurina, N.A. Red’kina, E.G. Gemdzhyan

  150-159

  01.04.2018

• The IVDG Regimen is the Possible Treatment of Choice as First Line Therapy For Hodgkin’s Lymphoma in Elderly Patients with Cardiovascular and Pulmonary Comorbidity

  Kamil’ Daniyalovich Kaplanov, T.Yu. Klitochenko, A.L. Shipaeva, M.N. Shirokova, I.V. Matveeva, N.B. Lavrishina

  358-365

  01.07.2017

• Chronic Myeloid Leukemia Patient Registry in the Russian Federation: From Observational Studies to the Efficacy Evaluation in Clinical Practice

  Anna Grigor’evna Turkina, N.V. Novitskaya, A.K. Golenkov, V.A. Shuvaev, L.I. Napso, I.V. Krylova, A.M. Savrilova, G.Sh. Safuanova, A.V. Korobkin, T.Yu. Klitochenko, E.V. Burnasheva, E.V. Vasil’ev, O.M. Senderova, E.Yu. Fedorova, L.M. Yalunina, E.K. Nekhai, G.B. Kuchma, A.S. Lyamkina, N.G. Shchedrova

  390-401

  01.07.2017

• V(D)J Recombination Excision Circles of B- and T-cells as Prognostic Marker in B-Cell Chronic Lymphocytic Leukemia

  Igor’ Vladimirovich Obraztsov, M.A. Gordukova, N.A. Severina, B.V. Biderman, S.Yu. Smirnova, A.B. Sudarikov, E.A. Nikitin, A.G. Rumyantsev

  131-140

  01.04.2017

• A Case Report of Myeloid Sarcoma in a Child

  Timur Teimurazovich Valiev, A.M. Kovrigina, T.R. Panferova, T.L. Ushakova, I.N. Serebryakova, N.N. Tupitsyn, L.Yu. Grivtsova, I.I. Matveeva, E.V. Mikhailova, A.V. Popa, G.L. Menkevich

  218-226

  01.04.2017

• Acute Myeloblastic Leukemia and Myelodysplastic Syndrome: Azacitidine for Prophylactic and Preventive Purposes after Allogeneic Hematopoietic Stem Cell Transplantation

  Varvara Nikolaevna Ovechkina, S.N. Bondarenko, E.V. Morozova, I.S. Moiseev, O.A. Slesarchuk, A.G. Smirnova, O.S. Uspenskaya, Ya.V. Gudozhnikova, A.A. Osipova, V.S. Sergeev, N.N. Mamaev, L.S. Zubarovskaya, B.V. Afanas’ev

  45-51

  01.01.2017

• Rearrangement of 11q23 Chromosome Region in Acute Myeloid Leukemias in Children

  Elena Vol’fovna Fleishman, O.I. Sokova, A.V. Popa, G.A. Tsaur, L.N. Konstantinova, O.M. Plekhanova, M.V. Strigaleva, E.S. Nokhrina, V.S. Nemirovchenko, O.R. Arakaev

  446-455

  01.10.2016

• Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemias with Hyperdiploid Karyotype

  Tat’yana Leonidovna Gindina, N.N. Mamaev, E.S. Nikolaeva, S.N. Bondarenko, O.A. Slesarchuk, A.S. Borovkova, S.V. Razumova, O.V. Pirogova, A.L. Alyanskii, L.S. Zubarovskaya, B.V. Afanas’ev

  383-390

  01.10.2016

• Polycythemia Vera: Literature Review and Own Data

  Irina Nikolaevna Subortseva, T.I. Kolosheinova, E.I. Pustovaya, E.K. Egorova, A.M. Kovrigina, Yu.V. Pliskunova, T.V. Makarik, A.O. Abdullaev, A.L. Melikyan

  397-412

  01.10.2015

• Acute Myeloid Leukemias: 10-Year Therapy Experience

  Ol’ga Yur’evna Baranova, A.S. Antipova, O.D. Zakharov, N.A. Falaleeva, G.I. Kaletin, A.D. Shirin, G.R. Arakelyan, N.N. Tupitsyn, M.A. Frenkel’, N.A. Kupryshina, T.N. Obukhova, E.V. Domracheva, V.B. Larionova, E.V. Ogorodnikova, E.A. Osmanov

  287-301

  01.07.2015

• Bone Marrow Transplantation in Patients with Acute Lymphoblastic Leukemia with Extremely Poor Prognosis: Literature Review and Case Report

  Natal’ya Nikolaevna Subbotina, A.V. Popa, I.S. Dolgopolov, V.K. Boyarshinov, R.I. Pimenov, V.V. Dailidite, G.L. Mentkevich

  331-336

  01.07.2015

• Complex Karyotype in Pediatric Acute Myeloid Leukemia

  Elena Vol’fovna Fleischman, O.I. Sokova, A.V. Popa, I.I. Kalinina, L.N. Konstantinova

  151-160

  01.04.2015

• Haploidentical hematopoietic stem cell transplantation in children with acute myeloid leukemia: evolution of method and our data

  N.N. Subbotina, I.S. Dolgopolov, A.V. Popa, V.K. Boyarshinov, R.I. Pimenov, G.L. Mentkevich

  131-136

  01.04.2014

• Importance of biochemical studies of brain natriuretic peptide in patients with diffuse large B-cell lymphoma

  M.O. Yegorova, Ye.N. Komolova, S.Ye. Samsonova

  239-242

  01.04.2014

• Cytogenetic remission as an important criterion for treatment efficacy in pediatric acute myeloid leukemia

  E.W. Fleischman, O.I. Sokova, A.V. Popa, V.S. Nemirovchenko, L.N. Konstantinova, N.F. Metelkova

  148-156

  01.04.2013